Latest Investments News

Australian Unity Office Fund has declined a revised $54.5 million offer for its Brisbane property at 150 Charlotte Street after the purchaser defaulted on the original contract. The fund now awaits the purchaser's next move before the September 8 deadline.

Pearl Gull Iron Limited has agreed to sell its Cockatoo Island Project for A$4.5 million in cash, a 4% equity stake in Crestlink Pty Ltd, and ongoing royalties, marking a strategic shift as it seeks new growth opportunities.

Lotus Resources has completed a A$65 million placement to bolster its uranium projects in Malawi and Botswana, positioning itself for steady production and future expansion.

Austral Resources Australia Ltd has launched a $40 million placement at 5 cents per share to fund the acquisition and recommissioning of the Rocklands copper project in Queensland. The offer includes share and option issues tied to debt conversions and is conditional on shareholder approval and ASX reinstatement.

SunRice reported steady FY25 financials with improved profitability despite revenue pressure, while advancing its 2030 Growth Strategy amid industry headwinds and leadership transition.

FMR Resources has raised $3.4 million through a strategic equity placement to accelerate exploration at its Southern Porphyry target in Chile, aiming to unlock significant copper and gold potential.

Lion Energy has agreed to sell its minority interest in the Seram Non-Bula PSC for US$1.2 million, refocusing its efforts on the higher-potential East Seram PSC exploration program.

Savana Asset Management signals a strategic shift favoring US small caps amid easing Federal Reserve rates and cooling enthusiasm for mega-cap tech stocks. Kohl’s standout earnings further boost the fund’s outlook.

Novo Resources has initiated its first reverse circulation drilling at the Sherlock Crossing gold-antimony prospect, while advancing exploration at its Wyloo polymetallic project and NSW gold assets, signaling a busy second half of 2025.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Control Bionics Limited has announced a 1-for-5 non-renounceable rights issue to raise up to $2.06 million, aiming to fund the commercial expansion of its NeuroStrip® device and operational growth. The offer is partially underwritten and open to eligible shareholders in Australia and New Zealand.